The present invention relates to novel compounds which are able to modulate b-raf kinases, and the use of such compounds in the treatment of various diseases, disorders or conditions.
本发明涉及一种新的化合物,能够调节B-raf激酶,并将这种化合物用于治疗各种疾病,障碍或病况。
Type II Raf kinase inhibitors
申请人:Gray Nathanael S.
公开号:US09180127B2
公开(公告)日:2015-11-10
The present invention relates to novel compounds which are able to modulate b-raf kinases, and the use of such compounds in the treatment of various diseases, disorders or conditions.
本发明涉及一种新型化合物,能够调节B-raf激酶,并将此类化合物用于治疗各种疾病、障碍或病况。
Type II RAF kinase inhibitors
申请人:Dana-Farber Cancer Institute, Inc.
公开号:US09358231B2
公开(公告)日:2016-06-07
The present invention relates to novel compounds which are able to modulate b-raf kinases, and the use of such compounds in the treatment of various diseases, disorders or conditions.